SEC Form 4 research
| Issuer | OnKure Therapeutics, Inc. |
|---|---|
| Tickers | RPHM, OKUR |
| Reporting owners | 56 |
| Officers and directors | 9 |
| Last public filing | 2026-09-23 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-23 | 2026-09-21 | Saccomano Nicholas A | S | 87 | $2.97 | Not reported |
| 2026-09-23 | 2026-09-21 | Leverone Jason A. | S | 302 | $2.97 | Not reported |
| 2026-08-11 | 2026-08-07 | Hartley Dylan | A | 137,603 | Not reported | Not reported |
| 2026-08-11 | 2026-08-07 | Hartley Dylan | A | 50,000 | $0 | Not reported |
| 2026-08-11 | 2026-08-07 | Phillips Andrew John | A | 22,350 | $0 | Not reported |
| 2026-08-11 | 2026-08-07 | Jansen Valerie Malyvanh | A | 22,350 | $0 | Not reported |
| 2026-08-11 | 2026-08-07 | Agresta Samuel | A | 131,396 | Not reported | Not reported |
| 2026-08-11 | 2026-08-07 | Agresta Samuel | A | 18,588 | Not reported | Not reported |
| 2026-08-11 | 2026-08-07 | Agresta Samuel | A | 50,000 | $0 | Not reported |
| 2026-08-11 | 2026-08-07 | Leverone Jason A. | A | 130,611 | Not reported | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.